Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA
Cancer. 2013 119 (24): 4268-76

PMID: 24114811 · DOI:10.1002/cncr.28365

MeSH Terms (18)

Administration, Topical Adolescent Adult Aged Antineoplastic Agents Female Head and Neck Neoplasms Humans Induction Chemotherapy Lactococcus lactis Male Middle Aged Mouth Mucosa Mouthwashes Stomatitis Trefoil Factor-1 Tumor Suppressor Proteins Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links